Home Cart 0 Sign in  
X

[ CAS No. 118276-06-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 118276-06-5
Chemical Structure| 118276-06-5
Chemical Structure| 118276-06-5
Structure of 118276-06-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 118276-06-5 ]

Related Doc. of [ 118276-06-5 ]

Alternatived Products of [ 118276-06-5 ]

Product Details of [ 118276-06-5 ]

CAS No. :118276-06-5 MDL No. :MFCD06797917
Formula : C7H4F2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :SKOYTQILPMNZQO-UHFFFAOYSA-N
M.W : 158.10 Pubchem ID :10192584
Synonyms :

Calculated chemistry of [ 118276-06-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.77
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.39 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.18
Log Po/w (XLOGP3) : 1.23
Log Po/w (WLOGP) : 2.32
Log Po/w (MLOGP) : 1.66
Log Po/w (SILICOS-IT) : 2.35
Consensus Log Po/w : 1.75

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.93
Solubility : 1.85 mg/ml ; 0.0117 mol/l
Class : Very soluble
Log S (Ali) : -1.61
Solubility : 3.87 mg/ml ; 0.0245 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.32
Solubility : 0.764 mg/ml ; 0.00483 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.05

Safety of [ 118276-06-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 118276-06-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 118276-06-5 ]
  • Downstream synthetic route of [ 118276-06-5 ]

[ 118276-06-5 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 100-97-0 ]
  • [ 28177-48-2 ]
  • [ 118276-06-5 ]
YieldReaction ConditionsOperation in experiment
58%
Stage #1: for 15 h; Inert atmosphere; Reflux
Stage #2: for 0.5 h; Cooling
This compoundwas preparedbased on the methodology described by Lawrence et al. [29] withsome modifications: 2,6-difluorophenol (0.300 g, 2.3 mmol) and hexamethylenetetramine(0.323 g, 2.3 mmol) were refluxed intrifluoroacetic acid (3.5 mL, 45.7 mmol) for 15 h under argon atmosphere.The product was concentrated, combined with 15 mL of icewater and stirred for 30 min. The resultant mixture was basified withNa2CO3 and extracted with dichloromethane. The aqueous phase wasacidified with HCl (1 mol L−1) and then extracted four times with dichloromethane.The organic fractions were collected, dried withMgSO4 and rotary-evaporated. The product is a cream solid (0.212 g,58percent yield) with a melting point of 116–118 °C.
Reference: [1] Journal of Fluorine Chemistry, 2003, vol. 123, # 1, p. 101 - 108
[2] Journal of Molecular Liquids, 2018, vol. 264, p. 327 - 336
[3] South African Journal of Chemistry, 1997, vol. 50, # 1, p. 40 - 47
[4] Chemical Communications, 2011, vol. 47, # 22, p. 6449 - 6451
[5] Journal of Medicinal Chemistry, 1989, vol. 32, # 2, p. 450 - 455
[6] Patent: WO2011/159297, 2011, A1, . Location in patent: Page/Page column 82-83
[7] Patent: US2011/313003, 2011, A1, . Location in patent: Page/Page column 24-25
[8] Patent: WO2014/69963, 2014, A1, . Location in patent: Paragraph 331-332
[9] Patent: WO2010/80537, 2010, A1, . Location in patent: Page/Page column 58
  • 2
  • [ 28177-48-2 ]
  • [ 76-05-1 ]
  • [ 118276-06-5 ]
YieldReaction ConditionsOperation in experiment
60% Reflux General procedure: A solution of the selected phenol (10 mmol) and hexamethylenetetramine (11 mmol, 1.550 g) in trifluoroacetic acid (10 mL) was stirred and heated at reflux overnight. After cooling to room temperature, the crude product mixture was evaporated under reduced pressure and the yellow residue obtained was poured into distilled water and crushed ice. The cream-colored solid that precipitated was filtered under reduced pressure, washed with distilled water and dried at room temperature under vacuum, yielding the desired compound as a white solid. See, e.g., (Scheme 1, Figure 2). Yield: 60percent, 940 mg; mp (°C): 117-119 (Lit. 116-118, see reference [41j);[N. I. Lawrence, L. A. Hepworth, D. Rennison, A. T. McGown, I. A. Hadfield, Synthesis and anticancer activity of fluorinated analogues of combretastatin A-4, I. Fluor. Chem. 123 (2003) 101-108.j ‘H NMR (400 MHz, CDC13):, ppm = 9.81 (1H, s, CH), 7.49 (2H, d, I = 7.2, ArH), 6.45 (1H, bs, OH); ‘3C NMR (100 MHz, CDC13): , ppm = 189.1, 151.8 (dd, J = 245.3 and 5.2 Hz), 139 (t, J = 16.0 Hz), 128.1 (t, J= 5.9 Hz), 113.2 (dd, J= 14.7 and 6.8 Hz); GC-MS (El): mlz (tR, mm) = 158 (7.69) Mt
Reference: [1] Patent: WO2016/80853, 2016, A1, . Location in patent: Paragraph 00307; 00308
[2] Nucleic Acids Research, 2017, vol. 45, # 18, p. 10380 - 10392
  • 3
  • [ 28177-48-2 ]
  • [ 118276-06-5 ]
Reference: [1] Patent: US2008/58412, 2008, A1, . Location in patent: Page/Page column 23
[2] Patent: WO2010/48207, 2010, A2, . Location in patent: Page/Page column 75-76
  • 4
  • [ 28177-48-2 ]
  • [ 118276-06-5 ]
Reference: [1] Patent: US2010/134052, 2010, A1,
  • 5
  • [ 118276-06-5 ]
  • [ 2967-54-6 ]
Reference: [1] Synlett, 2009, # 20, p. 3378 - 3382
[2] Tetrahedron Letters, 2011, vol. 52, # 10, p. 1074 - 1077
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 118276-06-5 ]

Fluorinated Building Blocks

Chemical Structure| 63954-77-8

[ 63954-77-8 ]

3,5-Difluoro-2-hydroxybenzaldehyde

Similarity: 0.90

Chemical Structure| 405-05-0

[ 405-05-0 ]

3-Fluoro-4-hydroxybenzaldehyde

Similarity: 0.90

Chemical Structure| 192927-69-8

[ 192927-69-8 ]

2,4-Difluoro-3-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 887584-91-0

[ 887584-91-0 ]

3,4-Difluoro-5-hydroxybenzaldehyde

Similarity: 0.87

Chemical Structure| 1023290-12-1

[ 1023290-12-1 ]

3-Fluoro-5-hydroxybenzaldehyde

Similarity: 0.84

Aryls

Chemical Structure| 63954-77-8

[ 63954-77-8 ]

3,5-Difluoro-2-hydroxybenzaldehyde

Similarity: 0.90

Chemical Structure| 405-05-0

[ 405-05-0 ]

3-Fluoro-4-hydroxybenzaldehyde

Similarity: 0.90

Chemical Structure| 192927-69-8

[ 192927-69-8 ]

2,4-Difluoro-3-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 887584-91-0

[ 887584-91-0 ]

3,4-Difluoro-5-hydroxybenzaldehyde

Similarity: 0.87

Chemical Structure| 1023290-12-1

[ 1023290-12-1 ]

3-Fluoro-5-hydroxybenzaldehyde

Similarity: 0.84

Aldehydes

Chemical Structure| 63954-77-8

[ 63954-77-8 ]

3,5-Difluoro-2-hydroxybenzaldehyde

Similarity: 0.90

Chemical Structure| 405-05-0

[ 405-05-0 ]

3-Fluoro-4-hydroxybenzaldehyde

Similarity: 0.90

Chemical Structure| 192927-69-8

[ 192927-69-8 ]

2,4-Difluoro-3-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 887584-91-0

[ 887584-91-0 ]

3,4-Difluoro-5-hydroxybenzaldehyde

Similarity: 0.87

Chemical Structure| 1023290-12-1

[ 1023290-12-1 ]

3-Fluoro-5-hydroxybenzaldehyde

Similarity: 0.84